On account of the biological functions of these genes, we ultimately selected LOXL2 (lysyl oxidase‐like 2), CDH1 (E‐cadherin 1, type 1), and FN1 (fibronectin 1) to integrate a three‐gene signature in ESCC. The gene discussed is LOXL2; the disease is esophageal squamous cell carcinoma.